(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
1.98% $ 40.69
Live Chart Being Loaded With Signals
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States...
Stats | |
---|---|
Volumen de hoy | 697 324 |
Volumen promedio | 1.34M |
Capitalización de mercado | 3.32B |
EPS | $0 ( 2024-03-28 ) |
Próxima fecha de ganancias | ( $-1.500 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.10 |
ATR14 | $0.0560 (0.14%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-30 | Mehta Kishan | Buy | 16 592 | Stock Option (Right to Buy) |
2024-04-30 | Heffernan Michael Thomas | Buy | 16 592 | Stock Option (Right to Buy) |
2024-04-30 | Gregory Julia P | Buy | 16 592 | Stock Option (Right to Buy) |
2024-04-30 | Hugin Robert J | Buy | 16 592 | Stock Option (Right to Buy) |
2024-04-30 | Antonijevic Irina | Buy | 16 592 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
97.07 |
Last 99 transactions |
Buy: 15 364 606 | Sell: 259 097 |
Volumen Correlación
Biohaven Pharmaceutical Correlación
10 Correlaciones Más Positivas | |
---|---|
THD | 0.906 |
KB | 0.888 |
SHG | 0.882 |
NUVB | 0.877 |
BKF | 0.871 |
MX | 0.866 |
YINN | 0.866 |
RAYC | 0.862 |
HBI | 0.859 |
EDC | 0.858 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Biohaven Pharmaceutical Correlación - Moneda/Commodity
Biohaven Pharmaceutical Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-3.37M (0.00 %) |
EPS: | $-5.73 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-3.37M (0.00 %) |
EPS: | $-5.73 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-1.39M (0.00 %) |
EPS: | $-12.75 |
Financial Reports:
No articles found.
Biohaven Pharmaceutical
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 for neuropsychiatric indications; and Verdiperstat, a product for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico